| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033257823 |
| P356 | DOI | 10.1038/SJ.BJC.6601896 |
| P932 | PMC publication ID | 2364765 |
| P698 | PubMed publication ID | 15162146 |
| P5875 | ResearchGate publication ID | 8544601 |
| P2093 | author name string | S H Choi | |
| S Kim | |||
| J E Lee | |||
| C K Park | |||
| Y J Park | |||
| D Y Kim | |||
| J O Park | |||
| W K Kang | |||
| C H Park | |||
| W Park | |||
| J H Noh | |||
| M K Kang | |||
| D H Lim | |||
| H R Nam | |||
| J S Heo | |||
| J W Joh | |||
| S J Huh | |||
| T S Sohn | |||
| Y C Ahn | |||
| Y I Kim | |||
| P2860 | cites work | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 |
| Lymph node metastases of gastric cancer. General pattern in 1931 patients | Q34680739 | ||
| Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study | Q34754369 | ||
| A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group | Q36467929 | ||
| Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group | Q36619190 | ||
| Lymph and blood capillaries of the human gastric mucosa. A morphologic basis for metastasis in early gastric carcinoma | Q42436607 | ||
| Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients | Q43727877 | ||
| Impact of adjuvant therapy on locally advanced adenocarcinoma of the stomach | Q44017597 | ||
| Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma | Q46319539 | ||
| Cancer Incidence in Korea. | Q53662243 | ||
| Patterns of failure following curative resection of gastric carcinoma | Q68637468 | ||
| Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist | Q69650051 | ||
| Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy | Q70287797 | ||
| Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma | Q70651042 | ||
| Evaluation of extensive lymph node dissection for carcinoma of the stomach | Q70813507 | ||
| Local recurrence of gastric adenocarcinomas after gastrectomy | Q70950861 | ||
| The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification | Q70979565 | ||
| New method to evaluate the therapeutic value of lymph node dissection for gastric cancer | Q72346738 | ||
| A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group | Q72664730 | ||
| Recurrence following curative resection for gastric carcinoma | Q73442414 | ||
| Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer | Q73552404 | ||
| An interim report upon the second look procedure for cancer of the stomach, colon, and rectum and for limited intraperitoneal carcinosis | Q73632381 | ||
| Extended lymph-node dissection for gastric cancer | Q74629358 | ||
| A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach | Q75738738 | ||
| Local recurrence following subtotal resection for gastric carcinoma | Q76250785 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastrectomy | Q827390 |
| chemoradiotherapy | Q5090613 | ||
| P304 | page(s) | 11-17 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view | |
| P478 | volume | 91 |
| Q40023074 | A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer |
| Q34141623 | A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomy |
| Q36824877 | A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma |
| Q61809817 | Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition |
| Q27022943 | Adjuvant chemoradiotherapy in gastric adenocarcinoma: about 34 cases and review of the literature |
| Q44819729 | Benefit of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis |
| Q36235715 | Chemoradiation for gastric cancer: controversies, updates and novel techniques |
| Q93004405 | Clinical Application of Circulating Tumor Cells in Gastric Cancer |
| Q37373075 | D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy |
| Q36187019 | Dosimetric and Clinical Influence of 3D Versus 2D Planning in Postoperative Radiation Therapy for Gastric Cancer |
| Q36216823 | Gastric carcinoma in China: Current status and future perspectives (Review) |
| Q89303203 | Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples |
| Q33410889 | Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study |
| Q82621840 | Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery |
| Q51431752 | Interobserver variability in target volume delineation in postoperative radiochemotherapy for gastric cancer. A pilot prospective study. |
| Q64076485 | Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach |
| Q64943892 | Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review. |
| Q60922986 | Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis |
| Q38917073 | Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea. |
| Q36324647 | Post-operative radiochemotherapy in patients with gastric cancer: one department's experience of 56 patients |
| Q34255467 | Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection? |
| Q38076429 | Postoperative adjuvant radiotherapy for patients with gastric adenocarcinoma |
| Q34571032 | Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction |
| Q33393039 | Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen) |
| Q36537080 | Postoperative chemoradiotherapy in high risk locally advanced gastric cancer |
| Q33430940 | Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer |
| Q39635658 | Radiation Induced Duodenal Stump Blowout! |
| Q38127627 | Radiotherapy for gastric cancer: a systematic review and meta-analysis |
| Q35419356 | Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience |
| Q36642921 | Reflections on adjuvant treatment of gastric cancer. |
| Q38500269 | Resected gastric cancer with D2 dissection: advances in adjuvant chemoradiotherapy and radiotherapy techniques |
| Q33403352 | Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer |
| Q41370888 | Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer. |
| Q34012551 | Role of radiation therapy in gastric adenocarcinoma |
| Q82058932 | Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer |
| Q34664433 | Surgical treatment of anastomotic recurrence after gastrectomy for gastric cancer |
| Q89176134 | Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study |
| Q55069791 | The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. |
| Q36377927 | Treatment for isolated loco-regional recurrence of gastric adenocarcinoma: does surgery play a role? |
| Q53167144 | Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin). |
| Q42759559 | Video-assisted thoracic surgery for esophagus for treating locally recurrent gastric cancer at the anastomotic site |
Search more.